Chi, Dennis

Publications

Sort by

Co-Author Network

selected publications

Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 18
Practical guidelines for triage to neoadjuvant chemotherapy in advanced ovarian cancer: Big risk, big reward…or too much risk?. Gynecologic oncology. 2020 Editorial Article GET IT
Times cited: 3
Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery. Journal of gynecologic oncology. 2020 Academic Article GET IT
Times cited: 31
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecologic oncology. 2019 Academic Article GET IT
Times cited: 84
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancer. Gynecologic oncology. 2018 Academic Article GET IT
Times cited: 19
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 48
Benign metastasizing leiomyomas thought to be nodal metastases in a case of ovarian cancer. 2017 GET IT
Times cited: 1
Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer. Oncology (Williston Park, N.Y.). 2017 Academic Article GET IT
Times cited: 5
Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 28
A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2017 Academic Article GET IT
Times cited: 12
Long-term survival after anterior pelvic exenteration and total vaginectomy for recurrent endometrial carcinoma with metastatic inguinal nodes at the time of surgery. 2016 GET IT
Times cited: 6
Clinical and genetic determinants of ovarian metastases from colorectal cancer. Cancer. 2016 Academic Article GET IT
Times cited: 57
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 14
Corrigendum to "Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center" [Gynecol. Oncol. 142 (2016) 13-18]. 2016 GET IT
Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 3
Neoadjuvant chemotherapy in ovarian cancer revisited. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 Academic Article GET IT
Times cited: 15
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 110
Primary debulking surgery for metastatic cervical adenocarcinoma: A case report. 2015 GET IT
Times cited: 1
There Is Nothing New Under the Sun. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Letter GET IT
Times cited: 2
Role of aggressive surgical cytoreduction in advanced ovarian cancer. Journal of gynecologic oncology. 2015 Review GET IT
Times cited: 132
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecologic oncology. 2015 Academic Article GET IT
Times cited: 19
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery. European radiology. 2015 Academic Article GET IT
Times cited: 45
Radical surgery in ovarian cancer. Current oncology reports. 2015 Review GET IT
Times cited: 22
Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance. American journal of obstetrics and gynecology. 2015 Academic Article GET IT
Times cited: 16
Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies. Radiographics : a review publication of the Radiological Society of North America, Inc. 2015 Review GET IT
Times cited: 27
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecologic oncology. 2014 Academic Article GET IT
Times cited: 201
Fellowship learning curve associated with completing a robotic assisted total laparoscopic hysterectomy. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 27
Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2013 Academic Article GET IT
Times cited: 24
Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. European radiology. 2013 Academic Article GET IT
Times cited: 13
Management of intravascular leiomyomatosis: laparoscopic surgery for ordinary uterine fibroids led to an extraordinary finding. 2013 GET IT
Times cited: 3
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic oncology. 2013 Academic Article GET IT
Times cited: 47
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 30
Clinical implications of pleural effusions in ovarian cancer. Respirology (Carlton, Vic.). 2012 Academic Article GET IT
Times cited: 25
Covered esophageal self-expandable metal stents in the nonoperative management of postoperative colorectal anastomotic leaks. Gastrointestinal endoscopy. 2012 Academic Article GET IT
Times cited: 16
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery. AJR. American journal of roentgenology. 2012 Academic Article GET IT
Times cited: 18
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 11
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 37
Neoadjuvant chemotherapy is rarely the easy way out. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Letter GET IT
Times cited: 3
A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin. 2012 GET IT
Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 22
Re: defining the limits of radical cytoreductive surgery in ovarian cancer. Gynecologic oncology. 2012 Letter GET IT
Times cited: 2
Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery. Journal of gynecologic oncology. 2011 Academic Article GET IT
Times cited: 18
Current surgical management of ovarian cancer. Hematology/oncology clinics of North America. 2011 Review GET IT
Times cited: 35
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 46
Is the easier way ever the better way?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 66
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. British journal of cancer. 2011 Academic Article GET IT
Times cited: 119
A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection. Annals of surgical oncology. 2011 Academic Article GET IT
Times cited: 116
Epithelial ovarian cancer: focus on targeted therapy. Journal of oncology. 2011 Academic Article GET IT
Times cited: 4
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 35
Malignant melanoma of the vulva: an extension of cutaneous melanoma?. Gynecologic oncology. 2011 Academic Article GET IT
Times cited: 46
Recent surgical management of ovarian cancer. The journal of obstetrics and gynaecology research. 2011 Review GET IT
Times cited: 14
Clinical Approach to Diagnosis and Management of Ovarian, Fallopian Tube, and Peritoneal Carcinoma. Surgical pathology clinics. 2011 Review GET IT
Times cited: 2
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology. 2010 Academic Article GET IT
Times cited: 43
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 12
Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 168
Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survival. Radiology. 2010 Academic Article GET IT
Times cited: 70
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2010 Academic Article GET IT
Times cited: 31
Maximal cytoreductive effort in epithelial ovarian cancer surgery. Journal of gynecologic oncology. 2010 Academic Article GET IT
Times cited: 126
The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 162
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2010 Academic Article GET IT
Times cited: 15
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 34
Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 57
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 24
Vulvar mucinous adenocarcinoma associated with Crohn's disease: report of two cases. 2009 GET IT
Times cited: 6
Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2009 Academic Article GET IT
Times cited: 64
Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients. The Journal of urology. 2009 Academic Article GET IT
Times cited: 9
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 23
In response to: Establishing evidence for change in ovarian cancer surgery - Proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis. Gynecologic oncology. 2009 Letter GET IT
Times cited: 1
Observation on the surgical aspect of resection of noncolorectal nonneuroendocrine hepatic parenchymal metastasis in patients with primary epithelial ovarian carcinoma. Gynecologic oncology. 2009 Letter GET IT
Surgical management of recurrent ovarian cancer. Seminars in oncology. 2009 Review GET IT
Times cited: 47
Ultrasonic surgical aspiration for vaginal intraepithelial neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2009 Academic Article GET IT
Times cited: 13
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 43
Cytoreduction vs. neoadjuvant chemotherapy for ovarian cancer. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 21
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecologic oncology. 2008 Review GET IT
Times cited: 281
Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 40
Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology. 2008 Academic Article GET IT
Times cited: 39
Incidental findings at surgery--part 2. In brief. Current problems in surgery. 2008 Academic Article GET IT
Incidental findings at surgery-part 2. Current problems in surgery. 2008 Review GET IT
Times cited: 3
Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 78
Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series. Gynecologic oncology. 2008 Academic Article GET IT
Times cited: 69
Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography. Journal of computer assisted tomography. 2008 Academic Article GET IT
Times cited: 18
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 27
Operative management of primary epithelial ovarian cancer. Current oncology reports. 2007 Review GET IT
Times cited: 7
A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 124
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 58
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 62
Carcinosarcoma of the ovary treated with platinum and taxane: the memorial Sloan-Kettering Cancer Center experience. Gynecologic oncology. 2007 Academic Article GET IT
Times cited: 50
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors. Investigational new drugs. 2007 Academic Article GET IT
Times cited: 16
Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults. The American journal of surgical pathology. 2007 Academic Article GET IT
Times cited: 71
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2007 Academic Article GET IT
Times cited: 12
Extended pelvic resection of iliacus muscle and femoral nerve for isolated recurrent uterine cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 1
Superior pubic rami resection for isolated recurrent uterine cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 2
Distal partial gastrectomy and gastrojejunal anastomosis for recurrent ovarian cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 4
Hand-assisted laparoscopic splenectomy for isolated ovarian cancer recurrence. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 3
Liver mobilization and diaphragm peritonectomy/resection. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 22
The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 124
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 269
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Gynecologic oncology. 2006 Review GET IT
Times cited: 295
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 58
Surgical resection of recurrent endometrial carcinoma. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 53
Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 26
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy. Gynecologic oncology. 2006 Academic Article GET IT
Times cited: 7
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2006 Academic Article GET IT
Times cited: 30
p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2006 Academic Article GET IT
Times cited: 28
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 166
Successful pregnancies following fertility-preserving treatment for ovarian carcinoma. 2005 GET IT
Times cited: 3
Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma. Gynecologic oncology. 2005 Academic Article GET IT
Times cited: 47
Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 59
Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature. 2005 GET IT
Times cited: 13
Conservative management of pneumatosis intestinalis. 2005 GET IT
Times cited: 15
Fertility-sparing options for patients with gynecologic malignancies. The oncologist. 2005 Review GET IT
Times cited: 30
Celiac disease presenting as a paraneoplastic syndrome in a patient with synchronous endometrial and ovarian cancers. 2005 GET IT
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. International journal of radiation oncology, biology, physics. 2005 Academic Article GET IT
Times cited: 110
Borderline endometrioid tumor arising in a paratubal cyst: a case report. 2005 GET IT
Times cited: 14
Cervical cancer: current management of early/late disease. Surgical oncology clinics of North America. 2005 Review GET IT
Update on surgical treatment for endometrial cancer. Expert review of anticancer therapy. 2005 Review GET IT
Times cited: 3
Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer. Menopause (New York, N.Y.). 2005 Academic Article GET IT
Times cited: 12
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: A change in surgical approach. Women's Oncology Review. 2004 Article GET IT
The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 37
Anal dysplasia in HIV-infected women with cervical and vulvar dysplasia. Journal of lower genital tract disease. 2004 Academic Article GET IT
Times cited: 11
Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 44
Tertiary cytoreduction in patients with recurrent ovarian carcinoma. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 72
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 264
Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 34
Surgical cytoreduction in ovarian cancer. Oncology (Williston Park, N.Y.). 2004 Review GET IT
Times cited: 12
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 7
Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian cancer. Gynecologic oncology. 2004 Academic Article GET IT
Times cited: 6
Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecologic oncology. 2003 Academic Article GET IT
Times cited: 45
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecologic oncology. 2003 Academic Article GET IT
Times cited: 124
The use of MRI in the diagnosis and management of a bulky cervical carcinoma. 2003 GET IT
Times cited: 6
Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series. Gynecologic oncology. 2003 Academic Article GET IT
Times cited: 77
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecologic oncology. 2003 Academic Article GET IT
Times cited: 109
Clinically inapparent invasive vulvar carcinoma in an area of persistent Paget's disease: a case report. 2003 GET IT
Times cited: 5
Craniotomy for central nervous system metastases in epithelial ovarian carcinoma. Gynecologic oncology. 2002 Academic Article GET IT
Times cited: 29
Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report. 2002 GET IT
Times cited: 14
Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002 Academic Article GET IT
Times cited: 247
Recurrent cervical cancer. Current treatment options in oncology. 2002 Review GET IT
Times cited: 42
Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecologic oncology. 2001 Academic Article GET IT
Times cited: 203
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients. Gynecologic oncology. 2001 Academic Article GET IT
Times cited: 20
Surgical management of advanced or recurrent endometrial cancer. The Surgical clinics of North America. 2001 Review GET IT
Times cited: 23
Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. International journal of radiation oncology, biology, physics. 2001 Academic Article GET IT
Times cited: 63
Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer. Gynecologic oncology. 2001 Academic Article GET IT
Times cited: 18
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents. European journal of gynaecological oncology. 2001 Academic Article GET IT
Times cited: 1
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Gynecologic oncology. 2000 Academic Article GET IT
Times cited: 43
Advanced ovarian cancer. Current treatment options in oncology. 2000 Review GET IT
Times cited: 25
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000 Academic Article GET IT
Times cited: 465
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecologic oncology. 2000 Academic Article GET IT
Times cited: 171
Laparoscopy in gynecologic malignancies. Oncology (Williston Park, N.Y.). 1999 Review GET IT
Times cited: 17
The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa. Gynecologic oncology. 1999 Academic Article GET IT
Times cited: 10
Gynecologic cancer and laparoscopy. Obstetrics and gynecology clinics of North America. 1999 Review GET IT
Times cited: 15
Splenectomy in recurrent epithelial ovarian cancer. Gynecologic oncology. 1999 Review GET IT
Times cited: 69
Long-term experience in the surgical management of cancer of the uterine cervix. Seminars in surgical oncology. 1999 Review GET IT
Times cited: 23
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma. European journal of gynaecological oncology. 1999 Academic Article GET IT
Times cited: 2
Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings. Obstetrics and gynecology. 1999 Academic Article GET IT
Times cited: 149
Novel agents for intraperitoneal chemotherapy in patients with epithelial ovarian cancer. CME Journal of Gynecologic Oncology. 1998 Article
The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery. Seminars in oncology. 1998 Review GET IT
Times cited: 77
The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecologic oncology. 1997 Academic Article GET IT
Times cited: 105
Hepatic resection for metastatic gynecologic carcinomas. Gynecologic oncology. 1997 Review GET IT
Times cited: 54
The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecologic oncology. 1997 Review GET IT
Times cited: 85
Laparoscopic management of adnexal masses in women with a history of nongynecologic malignancy. 1995 GET IT
Times cited: 21
Serum ionized magnesium levels during intravenous MGSO4 therapy of preeclamptic women. Acta obstetricia et gynecologica Scandinavica. 1995 Academic Article GET IT
Times cited: 10

more ...

less ...

Background

education and training

M.D., New York University School of Medicine 1990
B.A., Columbia University 1986

Contact

full name

Dennis Chi

VIVO Weill Cornell Medical College

Dennis Chi Professor of Obstetrics and Gynecology

Publications

selected publications

Background

education and training

Contact

full name